Not Yet RecruitingN/Aketamine

Prospective Study of Induction Medications Used in the Trauma RSI

Sponsored by University of Southern California

NCT ID
NCT04291521
Target Enrollment
7,000 participants
Start Date
2026-01-01
Est. Completion
2028-07-30

About This Study

To compare the outcomes of the use of propofol, etomidate, and ketamine as induction agents for adult trauma patients undergoing intubation within 24 hours of admission. The primary goal is to determine the ideal agent that should be used in this patient population for intubations.

Conditions Studied

TraumaRapid Sequence Intubation

Interventions

  • Ketamine
  • Etomidate
  • Propofol

Eligibility

Age:18 Years - N/A
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* Trauma patients \>=18 yo requiring intubation within 24 hours of admission in either the ED or OR
* Patients received propofol, etomidate, or ketamine for induction agent

Exclusion Criteria:

* Patients who were intubated without induction agent medications
* Patients intubated outside of the hospital or in the field
* Patients who were intubated with an induction agent other than etomidate, ketamine, or propofol

Study Locations (1)

Keck School of Medicine of the University of Southern California
Los Angeles, California, United States

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Catherine M Kuza, MD
CONTACT
9089176330catherine.kuza@med.usc.edu
Jeffry T Nahmias, MD
CONTACT
9493073035jnahmias@uci.edu
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source